Over 80 different disease causing mutations in transthyretin (TTR) have bee
n reported. The vast majority are inherited in an autosomal dominant manner
and are related to amyloid deposition, affecting predominantly peripheral
nerve and/or the heart. A small portion of TTR mutations are apparently non
amyloidogenic. Among these are mutations responsible for hyperthyroxinemia
, presenting high affinity for thyroxine (a TTR ligand), Compound heterozyg
otic individuals for TTR mutants have been described; noteworthy is the cli
nically protective effect exerted by a non pathogenic over a pathogenic mut
ation. Current TTR mutations and their significance are briefly reviewed he
re. Hum Mutat 17:493-503, 2001. (C) 2001 Wiley-Liss, Inc.